Related references
Note: Only part of the references are listed.The regulation of FGF23 under physiological and pathophysiological conditions
Steffen Rausch et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2022)
The bone at the intersection of kidney and heart disease
Isaac Campos et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2022)
FGF23 signalling and physiology
Bryan B. Ho et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2021)
Hearing loss and dementia: radiologic and biomolecular basis of their shared characteristics. A systematic review.
Arianna Di Stadio et al.
NEUROLOGICAL SCIENCES (2021)
D-Serine Intervention In The Medial Entorhinal Area Alters TLE-Related Pathology In CA1 Hippocampus Via The Temporoammonic Pathway
Stephen Beesley et al.
NEUROSCIENCE (2021)
Association of sudden sensorineural hearing loss with dementia: a nationwide cohort study
Shu-Yu Tai et al.
BMC NEUROLOGY (2021)
The correlation between fibroblast growth factor-23 and ESRD patients with hearing impairment
Jingwen Nie et al.
PEERJ (2021)
D-Serine Mediates Cellular Proliferation for Kidney Remodeling
Atsushi Hesaka et al.
KIDNEY360 (2021)
N-methyl-D-aspartate receptor hyperfunction contributes to o-serine-mediated renal insufficiency
Yi-Shiou Tseng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2021)
Economic burden and cost-utility analysis of three renal replacement therapies in ESRD patients from Yunnan Province, China
Huixin Wu et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2020)
FGF23: Is It Another Biomarker for Phosphate-Calcium Metabolism?
Mariano Rodriguez
ADVANCES IN THERAPY (2020)
Utility of D-serine monitoring in kidney disease
Tomonori Kimura et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2020)
Relationship between GFR, intact PTH, oxidized PTH, non-oxidized PTH as well as FGF23 in patients with CKD
Shufei Zeng et al.
FASEB JOURNAL (2020)
Investigation of the relationship between sensorineural hearing loss and associated comorbidities in patients with chronic kidney disease: A nationwide, population-based cohort study
Kun-Lin Wu et al.
PLOS ONE (2020)
Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients
Ana Paula Silva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A Lancet Commission to address the global burden of hearing loss
Blake S. Wilson et al.
LANCET (2019)
Serine Racemase and D-serine in the Amygdala Are Dynamically Involved in Fear Learning
Darrick T. Balu et al.
BIOLOGICAL PSYCHIATRY (2018)
Insulin suppresses the production of fibroblast growth factor 23 (FGF23)
Ludmilla Baer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration
L. Yu Milovanova et al.
TERAPEVTICHESKII ARKHIV (2018)
D-serine, a novel uremic toxin, induces senescence in human renal tubular cells via GCN2 activation
Akira Okada et al.
SCIENTIFIC REPORTS (2017)
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
Valentin David et al.
KIDNEY INTERNATIONAL (2016)
Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages
Suguru Tanaka et al.
PLOS ONE (2016)
Nuclear Compartmentalization of Serine Racemase Regulates D-Serine Production IMPLICATIONS FOR N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ACTIVATION
Goren Kolodney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice
Ningyuan Sun et al.
SCIENTIFIC REPORTS (2015)
High dose D-serine in the treatment of schizophrenia
Joshua T. Kantrowitz et al.
SCHIZOPHRENIA RESEARCH (2010)
Cochlear function in chronic kidney disease and renal transplantation: A longitudinal study
K. S. Bains et al.
TRANSPLANTATION PROCEEDINGS (2007)